Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Get an introduction to all features of this page

Schott Pharma AG & Co. Kgaa Stock

Price
Target price
€21.80

€21.80

-0.230%
-0.05
-0.230%
-

-

 
Buy 3 Sell 0
Buy 3
Sell 0
14:07 / Tradegate WKN: A3ENQ5 / Name: Schott Pharma & Co. Kgaa / Stock / ? /
Latest predictions
13.02.26
47.51%
buy
12.02.26
47.32%
buy
06.06.25
-21.33%
buy
Show more
Best running prediction
-
13.02.26
47.51%
buy
Your prediction
Pros and Cons of Schott Pharma AG & Co. Kgaa in the next few years
Wizard

Schott Pharma AG & Co. Kgaa Stock

The price for the Schott Pharma AG & Co. Kgaa stock decreased slightly today. Compared to yesterday there is a change of -€0.050 (-0.230%).
What does Schott Pharma & Co. Kgaa do?

Pros and Cons of Schott Pharma AG & Co. Kgaa in the next few years

Pros
?
B****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice
Register To Post

News

EQS-News: SCHOTT Pharma with strong third quarter and on track for planned growthPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
EQS-News: SCHOTT Pharma with strong third quarter and on track for planned growth
EQS-News: SCHOTT Pharma with strong third quarter and on track for planned growth
eqs_en 
0 12.08.26
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma publishes preliminary Q3 key figures and raises 2026 revenue and earnings guidancePhoto, wide shot, wide-angle lens, Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma publishes preliminary Q3 key figures and raises 2026 revenue and earnings guidance
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma publishes preliminary Q3 key figures and raises 2026 revenue and earnings guidance
eqs_en 
0 08.07.26
EQS-News: SCHOTT Pharma mit robustem erstem Halbjahr und starkem CashflowPhoto, wide shot, wide-angle lens, Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
EQS-News: SCHOTT Pharma mit robustem erstem Halbjahr und starkem Cashflow
EQS-News: SCHOTT Pharma mit robustem erstem Halbjahr und starkem Cashflow
eqs_en 
0 13.05.26